Blood Saving Effect of Tranexame at Hip Joint Replacement

Abstract

Study of the efficacy (by the results of blood saving action assessment) and application safety of tranexamic acid (home antifibrinolytic drug Tranexame) at hip arthroplasty was performed. Perioperative blood loss (intraoperative + postoperative blood loss by drainages during 24 hours), need in hemotransfusion, laboratory indices (hemoglobin, hematocrit, coagulograms) before and after operation were analyzed in 43 patients. Twenty patients received 4 g of Tranexame daily (main group) and 23 patients did not receive antifibrinolytic drugs. In the main group reliable decrease in blood loss as compared with control perioperative one, lower decrease of hemoglobin level and less need for donor plasma transfusion (in combination with autodonor blood and other blood savings methods) was noted. Safety of the drug was proved by the absence of thrombosis signs at ultrasonography of lower extremities vessels.

Keywords

Tranexame (tranexamic acid) / hip joint replacement / antifibrinolytic action / blood saving effect

References

[1] Баркаган З.С. Геморрагические заболевания и синдромы. - М., 1980.

[2] Васильев С.А., Виноградов В.Л., Гемджян Э.Г. Транексам - антифибринолитический гемостатик //Тромбоз, гемостаз и реология. - 2008. - N 1. - С. 28-34.

[3] Шевченко Ю.Л., Стойко Ю.М., Замятин М.Н. и др. Кровесберегающий эффект транексамовой кислоты при протезировании коленного сустава //Общая реаниматология. - 2008. - N 6. - C. 1-4.

[4] Alvares J.C., Santiveri F.X., Ramos I. et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied //Rev. Esp. Anestesiol. Reanimatol. - 2008. - Vol. 55, N 2. - P. 75-80.

[5] Benoni G., Fredin H., Knebel R., Nilsson P. Blood conservation with tranexamic acid in total hip arthro-plasti: a randomized, double-blind study in 40 primary operations //Acta Orthop. Scand. - 2001. - Vol. 72. - P. 442-448.

[6] Blumberg N. Allogenic transfusion and infection: economic and clinical implications //Semin. Hematol. - 1997. - Vol. 34. - P. 34-40.

[7] Borghi B., Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopedic Anaesthesia //Eur. J. Anaesthesiol. - 2000. - Vol. 17. - P. 411-417.

[8] Brown J.R., Birkmeyer N.J.O., O'Connor G.T. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery //Circulation. - 2007. - Vol. 115. - P. 2801-2813.

[9] Casati V., Guzzon D., Oppizzi M. et al. Hemostatic effects of aprotinin, tranexamic acid and S-aminocaproic acid in primary cardiac surgery //Ann. Thorac. Surg. - 1999. - Vol. 68. - P. 2252-2257.

[10] Dietrich W., Spath P., Ebell A., Richter J.A. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations //J. Thorac. Cardiovasc. Surg. - 1997. - Vol. 113. - P. 194-201.

[11] Ekbдck G., Axelsson K., Ryttberg L. et al. Tranexamic acid reduces blood loss in total hip replacement surgery //Anesthet. Analg. - 2000. - Vol. 91. - P. 1124-1130.

[12] Engel J.M., Hohaus T., Ruwoldt R. et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin //Anesthet. Analg. - 2001. - Vol. 92. - P. 592-599.

[13] Innerhofer P., Walleczek C., Luz G. et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients //Transfusion. - 1999. - Vol. 39. - P. 625-632.

[14] Jansen A.J., Andreica S., Claeys M. et al. Use of tra-nexamic acid for an effective blood conservation stra-tegy after total knee arthroplasty //Br. J. Anaesth. - 1999. - Vol. 83. - P. 596-601.

[15] Mahdy A.M., Webster N.R. Perioperative systemic haemostatic agents //Br. J. Anaesth. - 2004. - Vol. 93. - P. 842-858.

[16] Murphy P., Heal J.M., Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions //Transfusion. - 1991. - Vol. 31. - P. 212-217.

[17] Murphy W.G., Davies M.J., Eduardo A. The haemostatic response to surgery and trauma //Br. J. Anaesth. - 1993. - Vol. 70. - P. 205-213.

[18] Risberg B. The response of the fibrinolytic system in trauma //Acta Chir. Scand. - 1985. - Vol. 522, Suppl. - P. 245-271.

[19] Shiga T., Wajima Z., Inoue T. et al. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials //Anesthet. Analg. - 2005. - Vol. 101. - P. 1602-1607.

[20] Spahn D.R., Casutt M. Eliminating blood transfusions: new aspects and perspectives //Anesthesiology. - 2000. - Vol. 93. - P. 242-255.

[21] Zufferey P., Merquiol F., Laporte S.M.Sc. et al. Do an-tifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? //Anesthesiology. - 2006. - Vol. 105. - P. 1034-1046.

RIGHTS & PERMISSIONS

Eco-Vector